Nom du produit:6,7-dimethoxy-3,4-dihydroquinazolin-4-one
IUPAC Name:6,7-dimethoxy-3,4-dihydroquinazolin-4-one
- CAS：13794-72-4
- Formule moléculaire：C10H10N2O3
- Pureté：97%
- Numéro de catalogue：CM104416
- Poids moléculaire：206.2
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:13794-72-4
- Formule moléculaire:C10H10N2O3
- Point de fusion:-
- Code SMILES:COC1=C(OC)C=C2C(=O)NC=NC2=C1
- Densité:
- Numéro de catalogue:CM104416
- Poids moléculaire:206.2
- Point d'ébullition:
- N° Mdl:MFCD01570147
- Stockage:
Category Infos
- Quinazolines
- Quinazolines belong to heterocyclic chemistry, also known as 1,3-naphthalenes. The backbone consists of two six-membered aromatic rings fused to each other, with two nitrogen atoms at positions 1 and 3 on the backbone. The presence of these two nitrogen atoms in quinazoline increases its importance in pharmaceutical and biological reactions. Quinazolines and their derivatives are among the most important heterocyclic compounds due to their diverse chemical reactivity and important range of biological activities.
Column Infos
- SE-9
- SE-9 is a novel dual-targeting SOS1/EGFR inhibitor that represents a promising treatment strategy for prostate cancer.
Multitarget medications represent an appealing therapy against the disease with multifactorial abnormalities─cancer. Therefore, simultaneously targeting son of sevenless 1 (SOS1) and epidermal growth factor receptor (EGFR), two aberrantly expressed proteins crucial for the oncogenesis and progression of prostate cancer, may achieve active antitumor effects.
Recherche 
+86 21 5895 0110 
